Results 1 to 10 of about 61,143,134 (63)

Formulation and in vitro evaluation of taste-masked oro-dispersible dosage form of diltiazem hydrochloride

Brazilian Journal of Pharmaceutical Sciences, 2011
Diltiazem hydrochloride is a calcium channel blocker generally indicated for the treatment of angina and hypertension, and it is extensively metabolized due to the hepatic metabolism.
Swati Changdeo Jagdale, Vaibhav Uttam Gawali, Bhanudas Shankar Kuchekar, Aniruddha Rajaram Chabukswar   +3 more
doaj   +2 more sources

Pharmacokinetics of diltiazem hydrochloride delay-onset sustained-release pellet capsules in healthy volunteers [PDF]

Brazilian Journal of Pharmaceutical Sciences, 2013
The pharmacokinetics (PK) of ordinary tablets and sustained release capsules of diltiazem hydrochloride in human clinical trials had been studied. The PK of diltiazem hydrochloride delay-onset sustained-release pellet capsules, a new dosage form, has not
Xi-Qing Yan, Zhi-Gang Chen, Rong-Liang Wang, Jun Yang, Fang Ai, Yan-Juan Pan, Pei-Yong Qiu, Da-Xin Wang   +7 more
doaj   +2 more sources

Biodegradable microparticulate drug delivery system of diltiazem HCl [PDF]

Brazilian Journal of Pharmaceutical Sciences, 2012
The efficacy of a drug in a specific application requires the maintenance of appropriate drug blood level concentration during a prolonged period of time.
Manish Kumar Gupta, Deepak Prakash, Brahmeshwar Mishra   +2 more
doaj   +2 more sources

Guideline for Chronic Coronary Syndrome - 2025. [PDF]

Arq Bras Cardiol
Cesar LAM, Gowdak LHW, Pavanello R, Ferreira JFM, Mioto BM, Poppi NT, Mendonça CMM, Beck ALS, Brito ASX, Abizaid A, Brandão AA, Falcão AMGM, Sposito A, Sousa ACS, Mansur AP, Macedo AVS, Chaves ÁJ, Falcão BAA, Markman Filho B, Nascimento BR, Jordão CP, Campos CAHM, Montenegro CEL, Rochitte CE, Serrano CV, Strunz CMC, Moreira DM, Watanabe DM, Lima EG, Gaui EN, Alexandre ERG, Rached FH, Jatene FB, Aguiar Filho GB, Feitosa-Filho GS, Pena HPM, Pinto IMF, Castro I, Scholz JR, Leal JCF, Mangione JA, Lima JJG, Faria Neto JR, Soares Junior J, Maia KAP, Carreira LCTF, Matos LDNJ, Dourado LOC, Sousa LLCM, Dallan LAO, Mastrocola LE, Gowdak MMG, França Neto OR, Coelho OR, Coelho-Filho OR, Behr PEB, Caramori PRA, Lemos Neto PA, Farsky PS, Santos Filho RDD, Lopes RD, Serra SM, Grobe SF, Montenegro ST, Barberato SH, Strabelli TMV, Burgos UMMC, Nina VJDS, Gomes WJ, Chalela WA, Mathias Junior W.   +70 more
europepmc   +1 more source

Randomized Study Comparing Radiofrequency Ablation with the PVAC Gold System vs. Antiarrhythmic Drugs in Elderly Patients with Symptomatic Atrial Fibrillation. [PDF]

Arq Bras Cardiol
Martins LCB, Pisani CF, Dorfman FK, Darrieux FCC, Wu TC, Ferraz AP, Hachul DT, Castro CC, Prado RRD, Souza LVF, Sacilloto L, Pessente GDA, Grupi CJ, Chokr MO, Nomura CH, Oliveira KR, Balbo CP, Melo SL, Veronese P, Scanavacca MI.   +19 more
europepmc   +1 more source

Cloridrato de tiletamina associado com cloridrato de zolazepam na tranqüilização e anestesia de calitriquídeos (Mammalia, Primates)

Arquivo Brasileiro De Medicina Veterinaria E Zootecnia, 1999
Júlio César Bicca-Marques
exaly  

Enhanced diltiazem bioavailability after oral administration of diltiazem with quercetin to rabbits

International Journal of Pharmaceutics, 2005
Jun-Shik Choi
exaly  

Características e propriedades de quitosanas purificadas nas formas neutra, acetato e cloridrato

Polimeros, 2001
Roberta Signini
exaly  

Pharmacokinetic interaction between diltiazem and morin, a flavonoid, in rats

Pharmacological Research, 2005
Jun-Shik Choi
exaly  

Enhanced oral exposure of diltiazem by the concomitant use of naringin in rats

International Journal of Pharmaceutics, 2005
Jun-Shik Choi
exaly